These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28973174)

  • 1. Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke: Secondary Analysis of the ENCHANTED Randomized Clinical Trial.
    Wang X; Robinson TG; Lee TH; Li Q; Arima H; Bath PM; Billot L; Broderick J; Demchuk AM; Donnan G; Kim JS; Lavados P; Lindley RI; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sharma VK; Thang NH; Wang JG; Woodward M; Anderson CS; Chalmers J;
    JAMA Neurol; 2017 Nov; 74(11):1328-1335. PubMed ID: 28973174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).
    Robinson TG; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Demchuk AM; Donnan GA; Kim JS; Lavados PM; Lee TH; Lindley RI; Martins SCO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Nguyen TH; Wang JG; Woodward M; Chalmers J; Anderson CS;
    Stroke; 2017 Jul; 48(7):1877-1883. PubMed ID: 28619989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke.
    Anderson CS; Robinson T; Lindley RI; Arima H; Lavados PM; Lee TH; Broderick JP; Chen X; Chen G; Sharma VK; Kim JS; Thang NH; Cao Y; Parsons MW; Levi C; Huang Y; Olavarría VV; Demchuk AM; Bath PM; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Ricci S; Roffe C; Pandian J; Billot L; Woodward M; Li Q; Wang X; Wang J; Chalmers J;
    N Engl J Med; 2016 Jun; 374(24):2313-23. PubMed ID: 27161018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of low-dose versus standard-dose alteplase in ischemic patients with prior stroke and/or diabetes mellitus: The ENCHANTED trial.
    Chen G; Wang X; Robinson TG; Pikkemaat M; Lindley RI; Zhou S; Ping L; Liu W; Liu L; Chalmers J; Anderson CS;
    J Neurol Sci; 2018 Apr; 387():1-5. PubMed ID: 29571842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
    Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
    Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.
    Anderson CS; Huang Y; Lindley RI; Chen X; Arima H; Chen G; Li Q; Billot L; Delcourt C; Bath PM; Broderick JP; Demchuk AM; Donnan GA; Durham AC; Lavados PM; Lee TH; Levi C; Martins SO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Silva F; Song L; Thang NH; Wardlaw JM; Wang JG; Wang X; Woodward M; Chalmers J; Robinson TG;
    Lancet; 2019 Mar; 393(10174):877-888. PubMed ID: 30739745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of Blood Pressure Lowering and Alteplase Dose in Acute Ischemic Stroke: Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study.
    Wang X; Song L; Yang J; Sun L; Moullaali TJ; Sandset EC; Delcourt C; Lindley RI; Robinson TG; Minhas JS; Arima H; Chalmers J; Kim JS; Sharma V; Wang JG; Pontes-Neto O; Lavados PM; Olavarría VV; Lee TH; Levi C; Martins SO; Thang NH; Anderson CS;
    Cerebrovasc Dis; 2019; 48(3-6):207-216. PubMed ID: 31812956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Dose vs Standard-Dose Alteplase in Acute Lacunar Ischemic Stroke: The ENCHANTED Trial.
    Zhou Z; Delcourt C; Xia C; Yoshimura S; Carcel C; Torii-Yoshimura T; You S; Malavera A; Chen X; Hackett ML; Woodward M; Chalmers J; Xu J; Robinson TG; Parsons MW; Demchuk AM; Lindley RI; Mair G; Wardlaw JM; Anderson CS
    Neurology; 2021 Mar; 96(11):e1512-e1526. PubMed ID: 33536271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Argatroban Plus Intravenous Alteplase vs Intravenous Alteplase Alone on Neurologic Function in Patients With Acute Ischemic Stroke: The ARAIS Randomized Clinical Trial.
    Chen HS; Cui Y; Zhou ZH; Dai YJ; Li GH; Peng ZL; Zhang Y; Liu XD; Yuan ZM; Jiang CH; Yang QC; Duan YJ; Ma GB; Zhao LW; Wang RX; Sun YL; Shen L; Wang EQ; Wang LH; Feng YF; Wang FY; Zou RL; Yang HP; Wang K; Wang DL; Wang YL;
    JAMA; 2023 Feb; 329(8):640-650. PubMed ID: 36757755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain Imaging Signs and Health-Related Quality of Life after Acute Ischemic Stroke: Analysis of ENCHANTED Alteplase Dose Arm.
    Chen X; Delcourt C; Sun L; Zhou Z; Yoshimura S; You S; Malavera A; Torii-Yoshimura T; Carcel C; Arima H; Hackett ML; Robinson T; Song L; Wang X; Lindley RI; Chalmers J; Anderson CS;
    Cerebrovasc Dis; 2020; 49(4):427-436. PubMed ID: 32702699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
    Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
    Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial.
    Barow E; Boutitie F; Cheng B; Cho TH; Ebinger M; Endres M; Fiebach JB; Fiehler J; Ford I; Galinovic I; Nickel A; Puig J; Roy P; Wouters A; Magnus T; Thijs V; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Gerloff C; Thomalla G;
    JAMA Neurol; 2019 Jun; 76(6):641-649. PubMed ID: 30907934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke: A Randomized Clinical Trial.
    van der Ende NAM; Roozenbeek B; Smagge LEM; Luijten SPR; Aerden LAM; Kraayeveld P; van den Wijngaard IR; Lycklama À Nijeholt GJ; den Hertog HM; Flach HZ; Postma AA; Roosendaal SD; Krietemeijer GM; Yo LSF; de Maat MPM; Nieboer D; Del Zoppo GJ; Meurer WJ; Lingsma HF; van der Lugt A; Dippel DWJ;
    JAMA Neurol; 2023 Jul; 80(7):714-722. PubMed ID: 37213122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial.
    Chen HS; Cui Y; Zhou ZH; Zhang H; Wang LX; Wang WZ; Shen LY; Guo LY; Wang EQ; Wang RX; Han J; Dong YL; Li J; Lin YZ; Yang QC; Zhang L; Li JY; Wang J; Xia L; Ma GB; Lu J; Jiang CH; Huang SM; Wan LS; Piao XY; Li Z; Li YS; Yang KH; Wang DL; Nguyen TN;
    JAMA; 2023 Jun; 329(24):2135-2144. PubMed ID: 37367978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial.
    Khatri P; Kleindorfer DO; Devlin T; Sawyer RN; Starr M; Mejilla J; Broderick J; Chatterjee A; Jauch EC; Levine SR; Romano JG; Saver JL; Vagal A; Purdon B; Devenport J; Pavlov A; Yeatts SD;
    JAMA; 2018 Jul; 320(2):156-166. PubMed ID: 29998337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applicability of ENCHANTED trial results to current acute ischemic stroke patients eligible for intravenous thrombolysis in England and Wales: Comparison with the Sentinel Stroke National Audit Programme registry.
    Robinson TG; Bray BD; Paley L; Sprigg N; Wang X; Arima H; Bath PM; Broderick JP; Durham AC; Kim JS; Lavados PM; Lee TH; Martins S; Nguyen TH; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sharma VK; Wang J; Woodward M; Rudd AG; Chalmers J; S Anderson C;
    Int J Stroke; 2019 Oct; 14(7):678-685. PubMed ID: 30961463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities between Asian and Non-Asian Thrombolyzed Acute Ischemic Stroke Patients in the Enhanced Control of Hypertension and Thrombolysis Stroke Trial.
    Chen C; Wang X; Chen X; Ouyang M; Sun L; Arima H; Robinson T; Lindley RI; Chalmers J; Li G; Song L; Anderson CS;
    Cerebrovasc Dis; 2021; 50(5):560-566. PubMed ID: 34153968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnicity and Other Determinants of Quality of Functional Outcome in Acute Ischemic Stroke: The ENCHANTED Trial.
    Chen X; Wang X; Delcourt C; Li J; Arima H; Hackett ML; Robinson T; Lavados PM; Lindley RI; Chalmers J; Anderson CS;
    Stroke; 2020 Feb; 51(2):588-593. PubMed ID: 31822251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-Lowering Pretreatment and Outcome Following Intravenous Thrombolysis for Acute Ischaemic Stroke: A Post Hoc Analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study Trial.
    Minhas JS; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Donnan GA; Kim JS; Lavados PM; Lee TH; Martins SCO; Olavarría VV; Pandian JD; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Thang NH; Wang JG; Woodward M; Chalmers J; Anderson CS; Robinson TG;
    Cerebrovasc Dis; 2018; 45(5-6):213-220. PubMed ID: 29705803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial.
    Bracard S; Ducrocq X; Mas JL; Soudant M; Oppenheim C; Moulin T; Guillemin F;
    Lancet Neurol; 2016 Oct; 15(11):1138-47. PubMed ID: 27567239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.